你认为4个月的生命价值多少?# Stock
k*x
1 楼
DNDN的股价在于你的认识
the overall survival advantage was a median of 4.1 months (at 50% survival,
25.8 months in the Provenge arm vs. 21.7 months in the placebo arm).
http://seekingalpha.com/article/308914-dendreon-new-trial-to-ex
the overall survival advantage was a median of 4.1 months (at 50% survival,
25.8 months in the Provenge arm vs. 21.7 months in the placebo arm).
http://seekingalpha.com/article/308914-dendreon-new-trial-to-ex